Total Funding
91
75
Total FundingSeries C raised
Growth Score
-6 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
375
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
Ben Lamm: Co-Founder and CEOPast Role: Conversable, Founder & CEO- Peter Phillips: Co-Founder & Chief Business OfficerPast Role: Marvel Entertainment, Executive Vice President/General Manager, Interactive & Distribution
About the Company
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Utilizing advanced gene editing technologies like CRISPR, the company aims to revive species such as the woolly mammoth and enhance ecosystems. Through innovative approaches, Colossal seeks to address the urgent
challenges of extinction and biodiversity loss.
